Roberto Bizzotto
Overview
Explore the profile of Roberto Bizzotto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma S, Dong Q, Haid M, Adam J, Bizzotto R, Fernandez-Tajes J, et al.
Diabetologia
. 2024 Sep;
67(12):2804-2818.
PMID: 39349772
Aims/hypothesis: Type 2 diabetes is a chronic condition that is caused by hyperglycaemia. Our aim was to characterise the metabolomics to find their association with the glycaemic spectrum and find...
2.
Eriksen R, White M, Dawed A, Perez I, Posma J, Haid M, et al.
J Clin Endocrinol Metab
. 2024 Apr;
109(9):e1697-e1707.
PMID: 38686701
Context: The role of glucagon-like peptide-1 (GLP-1) in type 2 diabetes (T2D) and obesity is not fully understood. Objective: We investigate the association of cardiometabolic, diet, and lifestyle parameters on...
3.
Chiriaco M, Nesti L, Flyvbjerg A, Golay A, Nazare J, Anderwald C, et al.
J Clin Endocrinol Metab
. 2023 Aug;
109(2):461-470.
PMID: 37650623
Context: The impact of obesity on glucose homeostasis has high interindividual variability, which may be partially explained by different adipokine concentrations. Leptin regulates energy balance and metabolism, and although its...
4.
Trico D, Mengozzi A, Baldi S, Bizzotto R, Olaniru O, Toczyska K, et al.
Metabolism
. 2022 Jun;
134:155247.
PMID: 35760117
Aims: Hypertriglyceridemia is associated with an increased risk of type 2 diabetes. We aimed to comprehensively examine the effects of hypertriglyceridemia on major glucose homeostatic mechanisms involved in diabetes progression....
5.
Cattai A, Merlanti R, Bizzotto R, Lucatello L, Capolongo F, Franci P
Vet Anaesth Analg
. 2022 May;
50(1):31-40.
PMID: 35550343
Objective: To investigate pharmacokinetics (PK) of fentanyl administered by target-controlled infusion (TCI), and to develop a PK model optimized by covariates for TCI in anaesthetized dogs. Study Design: Prospective clinical...
6.
Wesolowska-Andersen A, Brorsson C, Bizzotto R, Mari A, Tura A, Koivula R, et al.
Cell Rep Med
. 2022 Feb;
3(1):100477.
PMID: 35106505
The presentation and underlying pathophysiology of type 2 diabetes (T2D) is complex and heterogeneous. Recent studies attempted to stratify T2D into distinct subgroups using data-driven approaches, but their clinical utility...
7.
Bizzotto R, Trico D, Natali A, Gastaldelli A, Muscelli E, De Fronzo R, et al.
Diabetes Care
. 2021 Aug;
44(9):2115-2123.
PMID: 34362813
Objective: Endogenous insulin clearance (EIC) is physiologically reduced at increasing insulin secretion rate (ISR). Computing EIC at the prevailing ISR does not distinguish the effects of hypersecretion from those of...
8.
Mari A, Tura A, Grespan E, Bizzotto R
Front Physiol
. 2020 Dec;
11:575789.
PMID: 33324238
Mathematical modeling in the field of glucose metabolism has a longstanding tradition. The use of models is motivated by several reasons. Models have been used for calculating parameters of physiological...
9.
Bizzotto R, Jennison C, Jones A, Kurbasic A, Tura A, Kennedy G, et al.
Diabetes Care
. 2020 Dec;
44(2):511-518.
PMID: 33323478
Objective: We investigated the processes underlying glycemic deterioration in type 2 diabetes (T2D). Research Design And Methods: A total of 732 recently diagnosed patients with T2D from the Innovative Medicines...
10.
Eriksen R, Perez I, Posma J, Haid M, Sharma S, Thomas L, et al.
EBioMedicine
. 2020 Aug;
58:102932.
PMID: 32763829
Background: Dietary advice remains the cornerstone of prevention and management of type 2 diabetes (T2D). However, understanding the efficacy of dietary interventions is confounded by the challenges inherent in assessing...